Status: Recruiting
Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
PA9159 is a highly potent novel corticosteroid. The purpose of this study is to evaluate the safety, efficacy and characteristics of population pharmacokinetics of multiple dosing of PA9159 Inhalation Aerosol in patients with bronchial asthma.
Participants needed: 60
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Anhui Palo Alto Pharmaceuticals, Inc.Updated: Jan 8, 2026Locations: 1
Eligibility criteria
Aged 18 to 75 years inclusive, regardless of gender; [+4]
Subjects who are unable to correctly use a nebulizer, cannot tolerate nebulized... [+21]